Sci Signal:维生素C为何可能降低神经退行性疾病风险?

2017-04-08 佚名 学术经纬

最近,葡萄牙波尔图大学(Universidade do Porto)的研究人员发现了维生素C对大脑的另一项重要意义,那就是防止出现过度的炎症反应。



大脑的正常运作离不开维生素C。如果缺乏维生素C,多种神经递质的合成和传导会受阻,造成神经系统紊乱,而且还会增加阿兹海默症等神经退行性疾病的风险。

最近,葡萄牙波尔图大学(Universidade do Porto)的研究人员发现了维生素C对大脑的另一项重要意义,那就是防止出现过度的炎症反应。如果缺乏维生素C,中枢神经系统内的天然免疫细胞——小胶质细胞(microglia)会变得异常活跃,分泌大量的炎症因子,导致损伤和退行性病变。这一结果发表于《科学》子刊《Science Signaling》上。


▲小胶质细胞的活性转化(图片来源:jonlieffmd)

研究者发现,维生素C的这一作用是通过小胶质细胞膜上的钠离子依赖性维生素C转运体SVCT2实现的,后者负责将维生素C转运至胞内。当中枢神经系统受伤或者被细菌脂多糖(LPS)感染时,小胶质细胞就会活化,以行使免疫和修复等功能。实验显示,当大鼠的小胶质细胞被施以LPS时,其膜上的SVCT2含量就会减少,维生素C转运的速率也会降低。

SVCT2水平的降低会进一步引起小胶质细胞呈现炎症反应表型。在此时的小胶质细胞中,活性氧自由基(ROS)的产生会增多,而可被ROS激活的关键性炎症反应启动转录因子NF-kB也大量活化,集聚到核内DNA上以激活转录,使得多种炎症因子被高水平地合成和释放,如TNF、IL-1b和IL-6等。


▲SVCT2对小胶质细胞活化的调节机制(图片来源:《Science Signaling》)

SVCT2在这一过程中发挥关键作用。SVCT2基因杂合(SVCT2+/-)小鼠的小胶质细胞就处于过度活化的状态;SVCT2基因隐形纯合(SVCT2-/-)小鼠则会脑内大出血,在出生后很快死亡。同时,在SVCT2的上游,c-Src激酶进行着调控,可将支架蛋白Cav-1的Tyr14位点磷酸化以将其激活。Cav-1接着可介导膜上SVCT2的内化过程,使得后者最终于溶酶体中被降解。

研究者发现,施用维生素C、SVCT2过表达和SVCT2内化过程阻断都可有效地阻止小胶质细胞在LPS的诱导下被激活。因此,尽管小胶质细胞可在中枢神经系统内激发过度的炎症反应,上述结果为应对疗法的开发提供了有益的思路,有望用于神经退行性疾病和神经系统功能紊乱等的治疗。

原始出处:
Portugal CC,Socodato R,Canedo T, et al. Caveolin-1-mediated internalization of the vitamin C transporter SVCT2 in microglia triggers an inflammatory phenotype.Science Signaling,2017, 10(472).DOI: 10.1126/scisignal.aal2005

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1735369, encodeId=b1891e35369d6, content=<a href='/topic/show?id=740394686b2' target=_blank style='color:#2F92EE;'>#退行性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94686, encryptionId=740394686b2, topicName=退行性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0233899115, createdName=ZGMFX35A, createdTime=Fri Mar 09 05:07:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793972, encodeId=35181e9397231, content=<a href='/topic/show?id=7b3d1630617' target=_blank style='color:#2F92EE;'>#Signal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16306, encryptionId=7b3d1630617, topicName=Signal)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Mon Oct 23 09:07:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036147, encodeId=6aab203614ee6, content=<a href='/topic/show?id=ae7816304dc' target=_blank style='color:#2F92EE;'>#Sign#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16304, encryptionId=ae7816304dc, topicName=Sign)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Thu Apr 20 06:07:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957140, encodeId=867a195e1403d, content=<a href='/topic/show?id=5879e458629' target=_blank style='color:#2F92EE;'>#神经退行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74586, encryptionId=5879e458629, topicName=神经退行)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Fri Jul 14 17:07:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473045, encodeId=11c014e304595, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Apr 09 23:07:00 CST 2017, time=2017-04-09, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1735369, encodeId=b1891e35369d6, content=<a href='/topic/show?id=740394686b2' target=_blank style='color:#2F92EE;'>#退行性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94686, encryptionId=740394686b2, topicName=退行性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0233899115, createdName=ZGMFX35A, createdTime=Fri Mar 09 05:07:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793972, encodeId=35181e9397231, content=<a href='/topic/show?id=7b3d1630617' target=_blank style='color:#2F92EE;'>#Signal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16306, encryptionId=7b3d1630617, topicName=Signal)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Mon Oct 23 09:07:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036147, encodeId=6aab203614ee6, content=<a href='/topic/show?id=ae7816304dc' target=_blank style='color:#2F92EE;'>#Sign#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16304, encryptionId=ae7816304dc, topicName=Sign)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Thu Apr 20 06:07:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957140, encodeId=867a195e1403d, content=<a href='/topic/show?id=5879e458629' target=_blank style='color:#2F92EE;'>#神经退行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74586, encryptionId=5879e458629, topicName=神经退行)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Fri Jul 14 17:07:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473045, encodeId=11c014e304595, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Apr 09 23:07:00 CST 2017, time=2017-04-09, status=1, ipAttribution=)]
    2017-10-23 yaanren
  3. [GetPortalCommentsPageByObjectIdResponse(id=1735369, encodeId=b1891e35369d6, content=<a href='/topic/show?id=740394686b2' target=_blank style='color:#2F92EE;'>#退行性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94686, encryptionId=740394686b2, topicName=退行性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0233899115, createdName=ZGMFX35A, createdTime=Fri Mar 09 05:07:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793972, encodeId=35181e9397231, content=<a href='/topic/show?id=7b3d1630617' target=_blank style='color:#2F92EE;'>#Signal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16306, encryptionId=7b3d1630617, topicName=Signal)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Mon Oct 23 09:07:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036147, encodeId=6aab203614ee6, content=<a href='/topic/show?id=ae7816304dc' target=_blank style='color:#2F92EE;'>#Sign#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16304, encryptionId=ae7816304dc, topicName=Sign)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Thu Apr 20 06:07:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957140, encodeId=867a195e1403d, content=<a href='/topic/show?id=5879e458629' target=_blank style='color:#2F92EE;'>#神经退行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74586, encryptionId=5879e458629, topicName=神经退行)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Fri Jul 14 17:07:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473045, encodeId=11c014e304595, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Apr 09 23:07:00 CST 2017, time=2017-04-09, status=1, ipAttribution=)]
    2017-04-20 楚秀娟
  4. [GetPortalCommentsPageByObjectIdResponse(id=1735369, encodeId=b1891e35369d6, content=<a href='/topic/show?id=740394686b2' target=_blank style='color:#2F92EE;'>#退行性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94686, encryptionId=740394686b2, topicName=退行性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0233899115, createdName=ZGMFX35A, createdTime=Fri Mar 09 05:07:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793972, encodeId=35181e9397231, content=<a href='/topic/show?id=7b3d1630617' target=_blank style='color:#2F92EE;'>#Signal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16306, encryptionId=7b3d1630617, topicName=Signal)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Mon Oct 23 09:07:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036147, encodeId=6aab203614ee6, content=<a href='/topic/show?id=ae7816304dc' target=_blank style='color:#2F92EE;'>#Sign#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16304, encryptionId=ae7816304dc, topicName=Sign)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Thu Apr 20 06:07:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957140, encodeId=867a195e1403d, content=<a href='/topic/show?id=5879e458629' target=_blank style='color:#2F92EE;'>#神经退行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74586, encryptionId=5879e458629, topicName=神经退行)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Fri Jul 14 17:07:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473045, encodeId=11c014e304595, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Apr 09 23:07:00 CST 2017, time=2017-04-09, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1735369, encodeId=b1891e35369d6, content=<a href='/topic/show?id=740394686b2' target=_blank style='color:#2F92EE;'>#退行性疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=94686, encryptionId=740394686b2, topicName=退行性疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5a0233899115, createdName=ZGMFX35A, createdTime=Fri Mar 09 05:07:00 CST 2018, time=2018-03-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1793972, encodeId=35181e9397231, content=<a href='/topic/show?id=7b3d1630617' target=_blank style='color:#2F92EE;'>#Signal#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16306, encryptionId=7b3d1630617, topicName=Signal)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=102a153, createdName=yaanren, createdTime=Mon Oct 23 09:07:00 CST 2017, time=2017-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2036147, encodeId=6aab203614ee6, content=<a href='/topic/show?id=ae7816304dc' target=_blank style='color:#2F92EE;'>#Sign#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16304, encryptionId=ae7816304dc, topicName=Sign)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e9ed371, createdName=楚秀娟, createdTime=Thu Apr 20 06:07:00 CST 2017, time=2017-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1957140, encodeId=867a195e1403d, content=<a href='/topic/show?id=5879e458629' target=_blank style='color:#2F92EE;'>#神经退行#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=74586, encryptionId=5879e458629, topicName=神经退行)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=33b92500139, createdName=12498b37m72暂无昵称, createdTime=Fri Jul 14 17:07:00 CST 2017, time=2017-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1473045, encodeId=11c014e304595, content=<a href='/topic/show?id=862be0746bc' target=_blank style='color:#2F92EE;'>#疾病风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70746, encryptionId=862be0746bc, topicName=疾病风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3c757221906, createdName=花花1368, createdTime=Sun Apr 09 23:07:00 CST 2017, time=2017-04-09, status=1, ipAttribution=)]

相关资讯

盘点维生素C功能研究新近进展

维生素C(Vc,又称L-抗坏血酸)是高等灵长类动物与其他少数生物的必需营养素。抗坏血酸在大多的生物体可借由新陈代谢制造出来,但是人类是最显著的例外。最广为人知的是缺乏维生素C会造成坏血病。在生物体内,维生素C是一种抗氧化剂,保护身体免于自由基的威胁,维生素C同时也是一种辅酶。其广泛的食物来源为各类新鲜蔬果。 不过,人类不能自己制造人体必需的维生素C。这是因为人类本来用于制造维生素C的

BMJ:至今仍盛行的一种历史性疾病-案例报道

维生素C水平进行了检查,由于高度的临床怀疑开始口服抗坏血酸(100mg,三次日常)。接下来证实维生素C水平<5μmol/L(正常范围为15-90 μmol/L)。病人由营养师进行了评估,出院后伴随社区营养师随访计划。四周后患者疲劳和皮肤改变消失。6周后复查全血液计数,血红蛋白水平正常。

Cancer Cell:还在质疑高剂量维C抗癌?人体安全试验已通过

临床试验发现,定期给脑癌和肺癌患者注射800-1000倍日常服用量的维生素C作为改进常规癌症治疗效果的策略是安全的。在2017年3月30日提交的癌细胞研究工作报告中,爱荷华大学的研究人员展示了一令人惊讶的研究成果:改变癌细胞的铁代谢途径,导致癌细胞对高剂量维生素C引起的死亡敏感性增加。

Oncotarget:维生素C抗癌活力竟是肿瘤药物的十倍!

在一项最新发表国际知名肿瘤学杂志Oncotarget上的文章中,研究人员介绍了三种天然物质,三种实验药物以及一种在临床上用于抑制肿瘤干细胞(CSCs)生长的特效药。

Sci Signal:维生素C的新功能-预防小胶质细胞激活

总体而言,该研究的结果表明抗坏血酸转运系统对于维持小胶质细胞动态平衡的重要性,以及提示抗坏血酸转运失调可能参与了神经系统疾病的发生发展。

Sci signal:维生素C为何可能降低神经退行性疾病风险?

最近,葡萄牙波尔图大学(Universidade do Porto)的研究人员发现了维生素C对大脑的另一项重要意义,那就是防止出现过度的炎症反应。大脑的正常运作离不开维生素C。如果缺乏维生素C,多种神经递质的合成和传导会受阻,造成神经系统紊乱,而且还会增加阿兹海默症等神经退行性疾病的风险。最近,葡萄牙波尔图大学(Universidade do Porto)的研究人员发现了维生素C对大脑的另一项重要